NewAmsterdam Pharma Company
NAMS
#3983
Rank
A$3.84 B
Marketcap
$35.87
Share price
2.39%
Change (1 day)
13.39%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Cash on Hand

Cash on Hand as of September 2024 : A$0.68 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company has A$0.68 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NewAmsterdam Pharma Company - Cash on Hand chart (from 2023 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.49 B-32.22%
2022-12-31A$0.73 B685.16%
2021-12-31A$93.9 M507.14%
2020-12-31A$15.46 M